Top Stock Losers Today: CRBP, NAKA, QNTM Plummet on News

Font: Financial Modeling Prep  • May 26, 2026

Top Stock Market Losers Today: Analyzing Declines in Corbus Pharmaceuticals (NASDAQ:CRBP), Nakamoto Inc. (NASDAQ:NAKA), and More

• Several stocks experienced sharp price drops (20-30%) on unusually high trading volume, indicating strong selling pressure across the market.
• Many of these declines were directly linked to company-specific news, including clinical trial updates for biopharmaceutical firms and corporate developments for tech firms.
• The varied reasons for the sell-offs highlight the sensitivity of stock prices and investor sentiment to new information and competitive analysis.

Today's market saw several stocks fall sharply. The top market losers include Corbus Pharmaceuticals (NASDAQ:CRBP), Nakamoto Inc. (NASDAQ:NAKA), Quantum BioPharma (NASDAQ:QNTM), Octave Intelligence (OTCPK:OCTVV), and SuperX AI Technology (NASDAQ:SUPX). This market analysis reviews their performance and related company activities.

Corbus Pharmaceuticals experienced the steepest decline, falling 30.31% to $7.91 on massive trading volume of 3.65 million shares. This move follows the company's announcement of updated data from its CRB-701 cancer drug study. Despite the company noting "robust activity" in its findings, investor reaction led to a significant sell-off.

Other biopharmaceutical and tech firms also faced downturns. Quantum BioPharma dropped 23.70% to $7.05 after reaching a patient enrollment milestone in a key study. Meanwhile, Nakamoto Inc. fell 24.07% to $5.49 as it expanded its board by appointing its CIO. Both stocks saw high volume alongside these corporate developments.

Software provider Octave Intelligence decreased 20.69% to $17.25 on high volume, though no specific news was provided. SuperX AI Technology fell 20.31% to $9.77. This decline coincides with a recent analysis comparing the company to competitor Lowe’s (NYSE:LOW) as a potential investment, which may have influenced investor decisions.

In summary, the top market losers all saw significant price drops on unusually high trading volume. This indicates strong selling pressure. The declines appear linked to company-specific news, from clinical trial updates to competitive analysis, showing how sensitive stock prices can be to new information.